I'm posting this in response to an article on a conservative website where the author praises President Trump and condemns pharmaceutical company executives in the interest of saving money for Americans.
If there's a risk in having the government purchase private property, then there sure as hell is a risk in having the President of the United States work around trade rules to undermine the patent protection of pharmaceutical products.
I've read the negotiations follow these lines: If you don't offer it to us at a cheaper price, we'll make it ourselves.